The C’IL-LICO project proposes a new approach for the management of a group of rare and serious genetic diseases, ciliopathies that cause the deterioration of renal function and lead to end-stage renal failure. The project is led by Prof. Stanislas Lyonnet, director of the Imagine Hospital-University Institute (Paris).